Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14504) 14504
Book Review (2091) 2091
Publication (459) 459
Magazine Article (98) 98
Newsletter (72) 72
Book Chapter (39) 39
Conference Proceeding (20) 20
Book / eBook (14) 14
Newspaper Article (10) 10
Dissertation (6) 6
Reference (4) 4
Trade Publication Article (3) 3
Data Set (2) 2
Report (2) 2
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12641) 12641
humans (12628) 12628
female (6670) 6670
streptococcal infections - drug therapy (6155) 6155
male (6130) 6130
adult (3905) 3905
anti-bacterial agents - therapeutic use (3689) 3689
streptococcal infections - microbiology (3026) 3026
streptococcal infections - diagnosis (3016) 3016
child (3012) 3012
middle aged (2977) 2977
abridged index medicus (2794) 2794
streptococcal infections - complications (2417) 2417
adolescent (2338) 2338
aged (2080) 2080
child, preschool (2015) 2015
streptococcal infections (1958) 1958
animals (1821) 1821
infectious diseases (1675) 1675
pediatrics (1657) 1657
infant, newborn (1589) 1589
streptococcus pyogenes (1494) 1494
infant (1459) 1459
streptococcal infections - therapy (1440) 1440
infections (1358) 1358
microbiology (1336) 1336
streptococcal infections - epidemiology (1331) 1331
pregnancy (1203) 1203
staphylococcal infections - drug therapy (1162) 1162
penicillins - therapeutic use (1145) 1145
treatment outcome (1142) 1142
pharyngitis - drug therapy (1094) 1094
medicine, general & internal (1091) 1091
streptococcus pyogenes - isolation & purification (1083) 1083
streptococcus agalactiae (1061) 1061
antibiotics (1027) 1027
risk factors (1025) 1025
microbial sensitivity tests (1006) 1006
children (959) 959
streptococcal infections - etiology (935) 935
retrospective studies (917) 917
streptococcal infections - prevention & control (891) 891
diagnosis (838) 838
health aspects (834) 834
acute disease (806) 806
pharyngitis - microbiology (780) 780
disease (769) 769
immunology (766) 766
streptococcus - isolation & purification (766) 766
diagnosis, differential (751) 751
streptococcus agalactiae - isolation & purification (700) 700
anti-bacterial agents - administration & dosage (696) 696
endocarditis, bacterial - drug therapy (690) 690
infection (679) 679
streptococcus (674) 674
anti-bacterial agents - pharmacology (673) 673
surgery (663) 663
care and treatment (652) 652
penicillin (652) 652
pharmacology & pharmacy (612) 612
time factors (592) 592
pharyngitis (589) 589
research (574) 574
aged, 80 and over (563) 563
streptococcal infections - surgery (554) 554
drug therapy (544) 544
streptococcus pyogenes - drug effects (543) 543
management (536) 536
follow-up studies (528) 528
bacteria (523) 523
streptococcal infections - immunology (522) 522
streptococcal infections - veterinary (516) 516
prospective studies (509) 509
prevention (495) 495
drug resistance, microbial (494) 494
recurrence (494) 494
sepsis (489) 489
epidemiology (487) 487
streptococcal infections - pathology (483) 483
mice (480) 480
endocarditis, bacterial - microbiology (468) 468
tomography, x-ray computed (453) 453
pharyngitis - diagnosis (452) 452
bacteremia (451) 451
incidence (433) 433
combined modality therapy (427) 427
drug therapy, combination (423) 423
therapy (422) 422
endocarditis (419) 419
mortality (410) 410
penicillin g - therapeutic use (410) 410
streptococcus - drug effects (410) 410
meningitis (404) 404
prognosis (399) 399
old medline (393) 393
young adult (388) 388
obstetrics & gynecology (387) 387
tonsillitis - drug therapy (377) 377
prevalence (368) 368
infants (366) 366
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12390) 12390
French (531) 531
German (479) 479
Spanish (288) 288
Japanese (230) 230
Russian (215) 215
Italian (148) 148
Polish (65) 65
Dutch (61) 61
Danish (46) 46
Romanian (37) 37
Swedish (37) 37
Portuguese (30) 30
Norwegian (27) 27
Serbian (23) 23
Hungarian (20) 20
Hebrew (19) 19
Turkish (18) 18
Chinese (16) 16
Finnish (16) 16
Bulgarian (14) 14
Czech (14) 14
Croatian (4) 4
Slovak (4) 4
Ukrainian (3) 3
Korean (2) 2
Lithuanian (2) 2
Armenian (1) 1
Greek (1) 1
Icelandic (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: A comparative observational study
by Linnér, Anna and Darenberg, Jessica and Sjölin, Jan and Henriques-Normark, Birgitta and Norrby-Teglund, Anna and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Infektionssjukdomar and Uppsala universitet and Institutionen för medicinska vetenskaper
Clinical Infectious Diseases, ISSN 1058-4838, 09/2014, Volume 59, Issue 6, pp. 851 - 857
Background. Streptococcal toxic shock syndrome (STSS) and necrotizing fasciitis are the 2 most severe invasive manifestations caused by group A Streptococcus... 
Streptococcus pyogenes | Polyspecific intravenous immunoglobulin | Clindamycin | Necrotizing fasciitis | Streptococcal toxic shock syndrome | INFECTIOUS DISEASES | INFECTIONS | MANAGEMENT | IMMUNE GLOBULIN | M-PROTEIN | RISK | MICROBIOLOGY | IMMUNOLOGY | PATHOGENESIS | streptococcal toxic shock syndrome | polyspecific intravenous immunoglobulin | necrotizing fasciitis | clindamycin | MOLECULAR-BASIS | Prognosis | Prospective Studies | Age Factors | Humans | Middle Aged | Male | Shock, Septic - diagnosis | Shock, Septic - therapy | Streptococcal Infections - mortality | Streptococcus pyogenes - genetics | Anti-Bacterial Agents - therapeutic use | Aged, 80 and over | Adult | Female | Streptococcus pyogenes - classification | Odds Ratio | Streptococcal Infections - microbiology | Streptococcal Infections - therapy | Comorbidity | Treatment Outcome | Shock, Septic - mortality | Clindamycin - therapeutic use | Streptococcal Infections - diagnosis | Immunoglobulins, Intravenous - therapeutic use | Aged | Immunoglobulins | Care and treatment | Mortality | Physiological aspects | Streptococcal infections | Research | Risk factors | Infectious diseases | Regression analysis | Comparative analysis | Streptococcus infections | Index Medicus | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Infektionsmedicin | Infectious Medicine | Klinisk medicin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Assessment of acoustic pulse therapy (APT), a non-antibiotic treatment for dairy cows with clinical and subclinical mastitis
by Leitner, Gabriel and Zilberman, David and Papirov, Eduard and Shefy, Sela
PLoS ONE, ISSN 1932-6203, 07/2018, Volume 13, Issue 7, pp. e0199195 - e0199195
Clinical and subclinical mastitis affects 30% of cows and is regarded as the most significant economic burden on the dairy farm reducing milk yield and quality... 
SHOCK-WAVE THERAPY | MULTIDISCIPLINARY SCIENCES | ERECTILE DYSFUNCTION | LACTATION | MILK | STRATEGIES | Streptococcus - growth & development | Staphylococcal Infections - pathology | Therapies, Investigational - instrumentation | Escherichia coli - drug effects | Lactation - drug effects | Streptococcus - drug effects | Escherichia coli Infections - therapy | Mastitis, Bovine - pathology | Cattle | Mammary Glands, Animal - microbiology | Female | Streptococcal Infections - pathology | Staphylococcal Infections - microbiology | Escherichia coli - growth & development | Mastitis, Bovine - therapy | Streptococcal Infections - microbiology | Therapies, Investigational - methods | Streptococcal Infections - therapy | Mammary Glands, Animal - pathology | Staphylococcus - growth & development | Escherichia coli Infections - microbiology | Staphylococcus - drug effects | Treatment Outcome | Mammary Glands, Animal - drug effects | Sound | Mammary Glands, Animal - radiation effects | Ultrasonic Therapy - methods | Staphylococcal Infections - therapy | Mastitis, Bovine - microbiology | Animals | Escherichia coli Infections - pathology | Dairying | Anti-Bacterial Agents - pharmacology | Ultrasonic Therapy - instrumentation | Technology application | Medical research | Mastitis | Lactose | Antibiotics | Staphylococcal infections | Escherichia coli | Dairy cattle | Dairy farming | Medicine, Experimental | Health aspects | Milk production | Therapy | Glands | Central nervous system | Infections | Acoustics | Veterinary medicine | Subgroups | Animal lactation | Angiogenesis | Ischemia | Bacteria | Culling | Milk | Bacterial infections | Coagulase | Angina pectoris | Agricultural economics | Dairy farms | Dairy industry | Lithotripsy | Technology assessment | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text The Not-So-Good Prognosis of Streptococcal Periprosthetic Joint Infection Managed by Implant Retention: The Results of a Large Multicenter Study
by Lora-Tamayo, Jaime and Senneville, Éric and Ribera, Alba and Bernard, Louis and Dupon, Michel and Zeller, Valérie and Li, Ho Kwong and Arvieux, Céic and Clauss, Martin and Uçkay, Ilker and Vigante, Dace and Ferry, Tristan and Iribarren, José Antonio and Peel, Trisha N and Sendi, Parham and Miksic, Nina Gorišek and Roíguez-Pardo, Dolors and Del Toro, María Dolores and Fernández-Sampeo, Marta and Dapunt, Ulrike and Huotari, Kaisa and Davis, Joshua S and Palomino, Julián and Neut, Danielle and Clark, Benjamin M and Gottlieb, Thomas and Trebše, Rihard and Soriano, Alex and Bahamonde, Alberto and Guío, Laura and Rico, Alicia and Salles, Mauro J C and Pais, M José G and Benito, Natividad and Riera, Melchor and Gómez, Lucía and Aboltins, Craig A and Esteban, Jaime and Horcajada, Juan Pablo and O'Connell, Karina and Ferrari, Matteo and Skaliczki, Gábor and Juan, Rafael San and Cobo, Javier and Sánchez-Somolinos, Mar and Ramos, Antonio and Giannitsioti, Efthymia and Jover-Sáenz, Alfredo and Baraia-Etxaburu, Josu Mirena and Barbero, José María and Choong, Peter F M and Asseray, Nathalie and Ansart, Séverine and Moal, Gwenäel Le and Zimmerli, Werner and Ariza, Javier and Grp Investigators Streptococcal and Group of Investigators for Streptococcal Prosthetic Joint Infection and for the Group of Investigators for Streptococcal Prosthetic Joint Infection
Clinical Infectious Diseases, ISSN 1058-4838, 06/2017, Volume 64, Issue 12, pp. 1742 - 1752
Background.: Streptococci are not an infrequent cause of periprosthetic joint infection (PJI). Management by debridement, antibiotics, and implant retention... 
bone and joint infection | DAIR | rifampin | biofilm | ETIOLOGY | INFECTIOUS DISEASES | ANTIBIOTICS | DEBRIDEMENT | SUSCEPTIBILITY | GUIDELINES | RISK | MICROBIOLOGY | IMMUNOLOGY | PREDICTORS | STAPHYLOCOCCUS-AUREUS | PROSTHESIS | TREATMENT FAILURE | Prognosis | Arthritis, Infectious - drug therapy | Arthritis, Infectious - mortality | Humans | Salvage Therapy | Male | Arthritis, Infectious - microbiology | Prosthesis-Related Infections - drug therapy | Streptococcus agalactiae - isolation & purification | Anti-Bacterial Agents - therapeutic use | Prosthesis-Related Infections - microbiology | Treatment Failure | Female | Rifampin - therapeutic use | Retrospective Studies | Rifampin - administration & dosage | Arthritis, Infectious - therapy | Prosthesis-Related Infections - mortality | Biofilms - drug effects | Streptococcal Infections - therapy | Prosthesis-Related Infections - therapy | Debridement | Internationality | Streptococcal Infections - drug therapy | Aged | beta-Lactams - therapeutic use | Anti-Bacterial Agents - administration & dosage | beta-Lactams - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Acute haematogenous prosthetic joint infection: prospective evaluation of medical and surgical management
by Rodríguez, D and Pigrau, C and Euba, G and Cobo, J and García-Lechuz, J and Palomino, J and Riera, M and del Toro, M.D and Granados, A and Ariza, X and REIPI Grp Spanish Network Res Infe and REIPI Group (Spanish Network for Research in Infectious Disease)
Clinical Microbiology and Infection, ISSN 1198-743X, 12/2010, Volume 16, Issue 12, pp. 1789 - 1795
The optimum treatment for prosthetic joint infections has not been clearly defined. We report our experience of the management of acute haematogenous... 
treatment | Acute infection | antibiotic therapy | prosthetic joint infections | haematogenous infection | Haematogenous infection | Treatment | Prosthetic joint infections | Antibiotic therapy | INFECTIOUS DISEASES | RETENTION | DEBRIDEMENT | COMPONENTS | MICROBIOLOGY | IMPLANTS | TOTAL KNEE ARTHROPLASTY | TOTAL HIP-ARTHROPLASTY | THERAPY | RECOMMENDATIONS | EXPERIENCE | RETROSPECTIVE ANALYSIS | Arthroplasty, Replacement - adverse effects | Staphylococcal Infections - drug therapy | Prospective Studies | Humans | Risk Factors | Staphylococcal Infections - surgery | Gram-Negative Bacterial Infections - drug therapy | Treatment Outcome | Patient Care Management | Prosthesis-Related Infections - drug therapy | Prosthesis-Related Infections - therapy | Anti-Bacterial Agents - therapeutic use | Prosthesis-Related Infections - surgery | Streptococcal Infections - surgery | Case Management | Prosthesis-Related Infections - microbiology | Bacteremia - therapy | Treatment Failure | Female | Gram-Negative Bacterial Infections - surgery | Streptococcal Infections - drug therapy | Aged | Drug Therapy, Combination | Implants, Artificial | Prosthesis | Analysis | Staphylococcus aureus infections | Cross infection | Joint replacement | Nosocomial infections | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Group A streptococcal infections in children
by Steer, Andrew C and Danchin, Margaret H and Carapetis, Jonathan R
Journal of Paediatrics and Child Health, ISSN 1034-4810, 04/2007, Volume 43, Issue 4, pp. 203 - 213
The group A streptococcus causes the widest range of disease in humans of all bacterial pathogens. Group A streptococcal diseases are more common in children... 
impetigo | epidemiology | group A streptococcus | pharyngitis | acute rheumatic fever | post‐streptococcal glomerulonephritis | Group A streptococcus | Pharyngitis | Acute rheumatic fever | Post-streptococcal glomerulonephritis | Epidemiology | Impetigo | EPIDEMIOLOGIC FEATURES | NECROTIZING FASCIITIS | SKIN SORES | NORTHERN INDIA | HEART-DISEASE | ACUTE RHEUMATIC-FEVER | DOUBLE-BLIND | PEDIATRICS | TOXIC-SHOCK-SYNDROME | post-streptococcal glomerulonephritis | SORE THROAT | ACUTE GLOMERULONEPHRITIS | Pharyngitis - physiopathology | Pyoderma - drug therapy | Rheumatic Fever - drug therapy | Poverty | Humans | Victoria | Child, Preschool | Streptococcal Infections - epidemiology | Pharyngitis - epidemiology | Rheumatic Fever - physiopathology | Glomerulonephritis - drug therapy | Rheumatic Fever - epidemiology | Streptococcus pyogenes - pathogenicity | Pyoderma - epidemiology | Pharyngitis - drug therapy | Pyoderma - physiopathology | Streptococcal Infections - physiopathology | Streptococcal Infections - drug therapy | Streptococcal Vaccines | Streptococcal Infections - complications | Streptococcal Infections - immunology | Glomerulonephritis - physiopathology | Glomerulonephritis - epidemiology | Fasciitis, Necrotizing, epidemiology | Pharyngitis, diagnosis | Streptococcal Infections, physiopathology | Pharyngitis, drug therapy | Penicillin V, therapeutic use | Rheumatic Fever, epidemiology | Pyoderma, drug therapy | Rheumatic Heart Disease, diagnosis | Streptococcus pyogenes, immunology | Rheumatic Heart Disease, complications | Bacteremia, epidemiology | Bacteremia, therapy | Pneumonia, Bacterial, therapy | Streptococcus pyogenes | Penicillin G, Benzathine, therapeutic use | Child | Rheumatic Fever, diagnosis | Staphylococcal Skin Infections, pathology | Glomerulonephritis, epidemiology | Rheumatic Heart Disease, epidemiology | Antigens, Bacterial | Streptococcal Infections, epidemiology | Streptococcal Infections, complications | Penicillins, therapeutic use | Pharyngitis, microbiology | Pneumonia, Bacterial, epidemiology | Glomerulonephritis, diagnosis | Shock, Septic, epidemiology | Streptococcus pyogenes, pathogenicity | Shock, Septic, therapy | Rheumatic Fever, complications | Rheumatic Fever, therapy | Glomerulonephritis, therapy | Soft Tissue Infections, therapy | Streptococcal Infections, drug therapy | Anti-Bacterial Agents, therapeutic use | Fasciitis, Necrotizing, therapy | Soft Tissue Infections, epidemiology | Rheumatic Heart Disease, therapy | Glomerulonephritis, complications | Immunoglobulins, Intravenous | Pyoderma, microbiology | Health aspects | Australian aborigines | Children | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Irrigation and debridement for periprosthetic infections: Does the organism matter?
by Odum, Susan M and Fehring, Thomas K and Lombardi, Adolph V and Zmistowski, Ben M and Brown, Nicholas M and Luna, Jeffrey T and Fehring, Keith A and Hansen, Erik N and Berend, Keith R and Bozic, Kevin J and Valle, Craig J. Della and Gioe, Terence J and Jiranek, William A and Parvizi, Javad and Springer, Bryan D and Periprosthetic Infection and Periprosthetic Infection Consortium
Journal of Arthroplasty, ISSN 0883-5403, 2011, Volume 26, Issue 6, pp. 114 - 118
Irrigation and debridement (I&D) is an attractive treatment alternative for periprosthetic joint infection (PJI). Irrigation and debridement failure rates... 
Revision arthroplasty | Causative organism | Periprosthetic joint infection | UNITED-STATES | SALVAGE | REVISION | 2-STAGE REIMPLANTATION | SPACER | revision arthroplasty | RETENTION | PROSTHETIC JOINT INFECTION | TOTAL KNEE ARTHROPLASTY | HIP | TREATMENT OPTIONS | periprosthetic joint infection | causative organism | ORTHOPEDICS | Follow-Up Studies | Humans | Middle Aged | Male | Young Adult | Streptococcus - isolation & purification | Treatment Failure | Aged, 80 and over | Adult | Female | Knee Prosthesis - microbiology | Retrospective Studies | Debridement - methods | Streptococcal Infections - therapy | Treatment Outcome | Prosthesis-Related Infections - therapy | Staphylococcal Infections - therapy | Algorithms | Animals | Therapeutic Irrigation - methods | Staphylococcus - isolation & purification | Adolescent | Aged | Hip Prosthesis - microbiology | Cohort Studies | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Development of the nasopharyngeal microbiota in infants with cystic fibrosis
by Prevaes, Sabine M. P. J and De Winter-De Groot, Karin M and Janssens, Hettie M and De Steenhuijsen Piters, Wouter A. A and Tramper-Stranders, Gerdien A and Wyllie, Anne L and Hasrat, Raiza and Tiddens, Harm A and Van Westreenen, Mireille and Van Der Ent, Cornelis K and Sanders, Elisabeth A. M and Bogaert, Debby
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 03/2016, Volume 193, Issue 5, pp. 504 - 515
Rationale: Cystic fibrosis (CF) is characterized by early structural lung disease caused by pulmonary infections. The nasopharynx of infants is a major... 
Healthy controls | Cystic fibrosis | Microbiota | Nasopharynx | Longitudinal | microbiota | SMALL-COLONY VARIANTS | CARRIAGE | HAEMOPHILUS-INFLUENZAE | COMMUNITIES | CHILDREN | STREPTOCOCCUS-PNEUMONIAE | INHIBITION | RESPIRATORY SYSTEM | cystic fibrosis | INFLAMMATION | LUNG-DISEASE | STAPHYLOCOCCUS-AUREUS | longitudinal | nasopharynx | healthy controls | CRITICAL CARE MEDICINE | Carrier State - epidemiology | Streptococcus mitis - genetics | Prospective Studies | Humans | Corynebacterium Infections - epidemiology | Carrier State - microbiology | Haemophilus Infections - epidemiology | Infant | Male | Corynebacterium Infections - microbiology | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Enterobacteriaceae Infections - epidemiology | Female | Staphylococcal Infections - microbiology | Nasopharynx - microbiology | Real-Time Polymerase Chain Reaction | Burkholderia Infections - microbiology | Haemophilus Infections - drug therapy | Infant, Newborn | Staphylococcus aureus - genetics | Moraxellaceae Infections - epidemiology | Streptococcal Infections - microbiology | Burkholderia - genetics | Staphylococcal Infections - drug therapy | Burkholderia Infections - epidemiology | Cystic Fibrosis - microbiology | Enterobacteriaceae Infections - microbiology | Enterobacteriaceae - genetics | Moraxellaceae Infections - microbiology | Streptococcal Infections - epidemiology | Haemophilus influenzae - genetics | Corynebacterium - genetics | Cystic Fibrosis - epidemiology | Moraxellaceae Infections - drug therapy | DNA, Bacterial - genetics | Staphylococcal Infections - epidemiology | Corynebacterium Infections - drug therapy | Microbiota - genetics | Burkholderia Infections - drug therapy | Haemophilus Infections - microbiology | RNA, Ribosomal, 16S - genetics | Streptococcal Infections - drug therapy | Moraxella - genetics | Cohort Studies | Enterobacteriaceae Infections - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Characteristics and outcome of 27 elbow periprosthetic joint infections: results from a 14-year cohort study of 358 elbow prostheses
by Achermann, Y and Vogt, M and Spormann, C and Kolling, C and Remschmidt, C and Wüst, J and Simmen, B and Trampuz, A
Clinical Microbiology and Infection, ISSN 1198-743X, 03/2011, Volume 17, Issue 3, pp. 432 - 438
Elbow arthroplasty is increasingly performed in patients with rheumatic and post-traumatic arthritis. Data on elbow periprosthetic joint infection (PJI) are... 
Elbow arthroplasty | microbiology | periprosthetic joint infection | treatment outcome | surgical intervention | Treatment outcome | Periprosthetic joint infection | Microbiology | Surgical intervention | RHEUMATOID-ARTHRITIS | DIAGNOSIS | REVISION | INFECTIOUS DISEASES | MANAGEMENT | RIFAMPIN | SONICATION | IMPLANTS | REPLACEMENT | TOTAL HIP-ARTHROPLASTY | FLUID | Recurrence | Enterobacteriaceae Infections - diagnosis | Enterobacter cloacae | Follow-Up Studies | Humans | Middle Aged | Male | Young Adult | Anti-Bacterial Agents - therapeutic use | Prosthesis-Related Infections - microbiology | Actinomycetales Infections - drug therapy | Aged, 80 and over | Adult | Female | Streptococcus agalactiae | Staphylococcal Infections - drug therapy | Elbow Prosthesis - adverse effects | Enterobacteriaceae Infections - etiology | Prosthesis-Related Infections - etiology | Actinomycetales Infections - etiology | Treatment Outcome | Streptococcal Infections - etiology | Prosthesis-Related Infections - therapy | Staphylococcal Infections - diagnosis | Streptococcal Infections - diagnosis | Actinomycetales Infections - diagnosis | Streptococcal Infections - drug therapy | Aged | Elbow Prosthesis - microbiology | Cohort Studies | Enterobacteriaceae Infections - drug therapy | Staphylococcal Infections - etiology | Orthopedic surgery | Implants, Artificial | Prosthesis | Analysis | Anti-infective agents | Cross infection | Nosocomial infections | Health aspects | Osteoarthritis | Prostheses | Algorithms | Arthritis | Joint surgery | Drug therapy | Retention | Patients | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text An Outbreak of Streptococcus Endophthalmitis After Intravitreal Injection of Bevacizumab
by Goldberg, Roger A and Flynn, Harry W and Isom, Ryan F and Miller, Darlene and Gonzalez, Serafin
American Journal of Ophthalmology, ISSN 0002-9394, 2012, Volume 153, Issue 2, pp. 204 - 208.e1
Purpose To report a series of patients with Streptococcus endophthalmitis after injection with intravitreal bevacizumab prepared by the same compounding... 
Ophthalmology | PREVENTION | OPHTHALMOLOGY | MACULAR DEGENERATION | Intravitreal Injections | Humans | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Endophthalmitis - epidemiology | Bevacizumab | Anti-Bacterial Agents - therapeutic use | Angiogenesis Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Eye Infections, Bacterial - microbiology | Disease Outbreaks | Endophthalmitis - therapy | Aged, 80 and over | Drug Compounding | Female | Vitrectomy | Vitreous Body - microbiology | Eye Infections, Bacterial - therapy | Angiogenesis Inhibitors - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Streptococcal Infections - microbiology | Florida - epidemiology | Streptococcus mitis - isolation & purification | Streptococcal Infections - therapy | Streptococcal Infections - epidemiology | Combined Modality Therapy | Visual Acuity | Endophthalmitis - microbiology | Vancomycin - therapeutic use | Aged | Eye Infections, Bacterial - epidemiology | Streptococcus oralis - isolation & purification | Drug Contamination | Endophthalmitis | Angiogenesis inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Early diagnosis and treatment of necrotizing fasciitis can improve survival: an observational intensive care unit cohort study
by Bucca, Kelly and Spencer, Ryan and Orford, Neil and Cattigan, Claire and Athan, Eugene and McDonald, Anthony
ANZ Journal of Surgery, ISSN 1445-1433, 05/2013, Volume 83, Issue 5, pp. 365 - 370
Background The aim of this study was to describe the clinical characteristics, causative pathogens, clinical management and outcomes of patients presenting to... 
critical care | sepsis | necrotizing fasciitis | Critical care | Sepsis | Necrotizing fasciitis | SOFT-TISSUE INFECTIONS | MORTALITY | SURGERY | MANAGEMENT | DETERMINANTS | A STREPTOCOCCAL INFECTIONS | Enterobacteriaceae Infections - diagnosis | Humans | Middle Aged | Cross Infection - mortality | Fasciitis, Necrotizing - therapy | Gram-Positive Bacterial Infections - mortality | Male | Enterobacteriaceae Infections - therapy | Streptococcal Infections - mortality | Anti-Bacterial Agents - therapeutic use | Gram-Positive Bacterial Infections - microbiology | Female | Fasciitis, Necrotizing - mortality | Retrospective Studies | Fasciitis, Necrotizing - diagnosis | Cross Infection - therapy | Streptococcal Infections - microbiology | Gram-Positive Bacterial Infections - therapy | Intensive Care Units | Streptococcal Infections - therapy | Enterobacteriaceae Infections - microbiology | Enterobacteriaceae Infections - mortality | Streptococcus milleri Group - isolation & purification | Treatment Outcome | Combined Modality Therapy | Gram-Positive Bacterial Infections - diagnosis | Debridement | Streptococcus pyogenes - isolation & purification | Streptococcal Infections - diagnosis | Fasciitis, Necrotizing - microbiology | Cross Infection - diagnosis | Early Diagnosis | Hyperbaric Oxygenation | Morganella morganii - isolation & purification | Cohort Studies | Care and treatment | Mortality | Analysis | Pathogens | Intensive care | Medical diagnosis | Medical treatment | Clinical outcomes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Intravenous Immunoglobulin G Therapy in Streptococcal Toxic Shock Syndrome: A European Randomized, Double-Blind, Placebo-Controlled Trial
by Jessica Darenberg and Nahla Ihendyane and Jan Sjölin and Ewa Aufwerber and Sven Haidl and Per Follin and Jan Andersson and Anna Norrby-Teglund and The Streptlg Study Group and Streptlg Study Grp and StreptIg Study Group and The Streptlg Study Group and Medicincentrum and Institutionen för molekylär och klinisk medicin and Linköpings universitet and Infektionskliniken i Östergötland and Östergötlands Läns Landsting and Hälsouniversitetet and Infektionsmedicin
Clinical Infectious Diseases, ISSN 1058-4838, 8/2003, Volume 37, Issue 3, pp. 333 - 340
The efficacy and safety of high-dose intravenous polyspecific immunoglobulin G (IVIG) as adjunctive therapy in streptococcal toxic shock syndrome (STSS) were... 
Immunoglobulins | Cytokines | Major Articles | Toxicity | Superantigens | Mortality | Placebos | Sofas | Infections | Streptococcal infections | Adjuvant therapy | SWEDEN | ADJUNCTIVE TREATMENT | INFECTIOUS DISEASES | INFECTIONS | NEUTRALIZING ANTIBODIES | NECROTIZING FASCIITIS | MICROBIOLOGY | IMMUNOLOGY | PATHOGENESIS | GROUP-A STREPTOCOCCI | PYROGENIC EXOTOXINS | CHANGING EPIDEMIOLOGY | CYTOKINE PRODUCTION | Double-Blind Method | Streptococcal Infections - therapy | Humans | Middle Aged | Immunoglobulin G - therapeutic use | Male | Treatment Outcome | Shock, Septic - mortality | Shock, Septic - therapy | Streptococcal Infections - mortality | Shock, Septic - microbiology | Aged, 80 and over | Adult | Female | Aged | Immunoglobulins, Intravenous | Clinical trials | Care and treatment | Health aspects | Immunoglobulin G | Mandatory drug testing | Toxic shock syndrome | Index Medicus | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Clinical Evaluation of Youth with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): Recommendations from the 2013 PANS Consensus Conference
by Chang, Kiki and Frankovich, Jennifer and Cooperstock, Michael and Cunningham, Madeleine W and Latimer, M. Elizabeth and Murphy, Tanya K and Pasternack, Mark and Thienemann, Margo and Williams, Kyle and Walter, Jolan and Swedo, Susan E and PANS Collaborative Consortium and From the PANS Collaborative Consortium
Journal of Child and Adolescent Psychopharmacology, ISSN 1044-5463, 02/2015, Volume 25, Issue 1, pp. 3 - 13
On May 23 and 24, 2013, the First PANS Consensus Conference was convened at Stanford University, calling together a geographically diverse group of clinicians... 
Consensus Statement | SYDENHAM CHOREA | MIMICRY | PSYCHIATRY | ANTINUCLEAR ANTIBODIES | OBSESSIVE-COMPULSIVE DISORDER | CHILDREN | STREPTOCOCCAL INFECTIONS | PATHOGENESIS | COMMUNITY | DISEASE | PEDIATRICS | PHARMACOLOGY & PHARMACY | MYCOPLASMA-PNEUMONIAE INFECTION | Acute Disease | Obsessive-Compulsive Disorder - diagnosis | Streptococcal Infections - diagnosis | Streptococcal Infections - therapy | Practice Guidelines as Topic - standards | Humans | Obsessive-Compulsive Disorder - therapy | Autoimmune Diseases - therapy | Autoimmune Diseases - diagnosis | Child | Syndrome | Pediatrics | Conferences, meetings and seminars | Neuropsychiatry | Practice | Youth | Teenagers | Health aspects | Mental disorders | Autoimmune diseases | Neurological disorders | Children & youth | Streptococcus infections | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights